Giant cell arteritis (Disease Or Phenotype)

Id:9a5c4254-af43-5d88-9649-164a74275dbe

Linked to

	Label	Description
	Triamcinolone Acetonide indication Giant cell arteritis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	triamcinolone indication Giant cell arteritis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	prednisolone indication Giant cell arteritis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	2-[(4-Ethynyl-2-Fluorophenyl)amino]-3,4-Difluoro-N-(2-Hydroxyethoxy)benzamide indication Giant cell arteritis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

Triamcinolone Acetonide indication Giant cell arteritis

A Knowledge Graph Assertion from IDG

triamcinolone indication Giant cell arteritis

A Knowledge Graph Assertion from IDG

prednisolone indication Giant cell arteritis

A Knowledge Graph Assertion from IDG

2-[(4-Ethynyl-2-Fluorophenyl)amino]-3,4-Difluoro-N-(2-Hydroxyethoxy)benzamide indication Giant cell arteritis

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.